| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-06 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0004 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.17 | 0.0004 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |